Translational Stroke Research

metrics 2024

Innovating insights that bridge research and clinical practice.

Introduction

Translational Stroke Research, published by Springer, stands at the forefront of the intersection of cardiology, neurology, and neuroscience, specifically focusing on the latest advancements in stroke research from 2010 to 2024. With an impressive impact factor as evidenced by its Q1 rankings in Cardiology and Cardiovascular Medicine, Clinical Neurology, and Neuroscience, this journal is a vital resource for researchers, clinicians, and students alike. It holds significant recognition in the academic community, achieving notable rankings in Scopus, including 15th out of 387 in Cardiology and 17th out of 400 in Clinical Neurology, showcasing its impact and relevance in these critical fields. Although not an open-access journal, it provides access options through institutional subscriptions, thereby facilitating the sharing of influential research that has the potential to shape the mitigation and understanding of stroke and related conditions. Researchers and practitioners seeking to expand their knowledge and engage with cutting-edge findings will find Translational Stroke Research to be an indispensable addition to their scholarly resources.

Metrics 2024

SCIMAGO Journal Rank1.59
Journal Impact Factor3.80
Journal Impact Factor (5 years)5.10
H-Index72
Journal IF Without Self3.80
Eigen Factor0.01
Normal Eigen Factor1.12
Influence1.24
Immediacy Index0.60
Cited Half Life4.00
Citing Half Life7.60
JCI1.30
Total Documents1149
WOS Total Citations4021
SCIMAGO Total Citations12816
SCIMAGO SELF Citations1157
Scopus Journal Rank1.59
Cites / Document (2 Years)5.17
Cites / Document (3 Years)5.86
Cites / Document (4 Years)5.68

Metrics History

Rank 2024

Scopus

Cardiology and Cardiovascular Medicine in Medicine
Rank #15/387
Percentile 96.12
Quartile Q1
Neurology (clinical) in Medicine
Rank #17/400
Percentile 95.75
Quartile Q1
General Neuroscience in Neuroscience
Rank #9/113
Percentile 92.04
Quartile Q1

IF (Web Of Science)

CLINICAL NEUROLOGY
Rank 59/277
Percentile 78.90
Quartile Q1
NEUROSCIENCES
Rank 97/310
Percentile 68.90
Quartile Q2

JCI (Web Of Science)

CLINICAL NEUROLOGY
Rank 41/278
Percentile 85.25
Quartile Q1
NEUROSCIENCES
Rank 53/310
Percentile 82.90
Quartile Q1

Quartile History

Similar Journals

European Stroke Journal

Empowering professionals with cutting-edge stroke research.
Publisher: SAGE PUBLICATIONS LTDISSN: 2396-9873Frequency: 4 issues/year

The European Stroke Journal, published by SAGE Publications Ltd, is a pivotal resource in the domains of Cardiology and Neurology, reflecting its commitment to advancing knowledge and research in these critical areas of medicine. Since its inception in 2016, this journal has rapidly gained recognition, achieving a prestigious Q1 ranking in both Cardiology and Neurology (clinical) as of 2023, placing it among the top quartile publications in these fields. With a prominent position, ranked 65th and 72nd respectively in Scopus for Cardiology and Neurology, the journal caters to a diverse audience of researchers, clinicians, and students dedicated to improving stroke treatment and prevention strategies. Although it operates under a traditional access model, its impactful publications are essential for anyone involved in stroke research, ensuring they remain at the forefront of scientific developments and clinical practices.

ACTA NEUROLOGICA SCANDINAVICA

Connecting Research and Practice in Neuroscience
Publisher: WILEYISSN: 0001-6314Frequency: 12 issues/year

ACTA NEUROLOGICA SCANDINAVICA is a prestigious journal published by Wiley that has significantly contributed to the field of neurology and neuroscience since its inception in 1961. With a broad scope encompassing clinical and experimental research, this journal is esteemed for its rigorous peer-review process and high-quality publications. Located in the United Kingdom, it is recognized in the 2023 category quartiles as Q1 in Medicine (miscellaneous) and Q2 in both Neurology and Clinical Neurology, indicating its strong influence and relevance within the medical community. With an H-index demonstrating consistent citation impact, ACTA NEUROLOGICA SCANDINAVICA holds a Scopus rank of #86 out of 400 in Clinical Neurology, reflecting its contribution to advancing current knowledge and practice. Researchers, professionals, and students alike will find in this journal a valuable resource for the latest findings, discussions, and developments in understanding neurological disorders and treatments, furthering educational and clinical endeavors alike.

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES

Connecting Ideas, Inspiring Innovations in Neurology
Publisher: CAMBRIDGE UNIV PRESSISSN: 0317-1671Frequency: 6 issues/year

Canadian Journal of Neurological Sciences, published by Cambridge University Press, stands as a reputable source of knowledge in the field of neurology, dedicated to advancing research and clinical practice. With an ISSN of 0317-1671 and an E-ISSN of 2057-0155, this journal has been a cornerstone for the exchange of ideas since its inception in 1974 and will continue to cater to the academic community until 2024. Recognized in the top quartile (Q2) in various categories including Medicine (miscellaneous) and Neurology (clinical), its articles engage a broad audience, ranging from established researchers to students seeking to deepen their understanding of neurological sciences. Although the journal is not an open-access publication, it provides vital insights and research findings that contribute significantly to its fields. With a Scopus rank of #183 in clinical neurology and a percentile ranking that reflects its commendable standing, the Canadian Journal of Neurological Sciences is indispensable for those committed to the exploration and treatment of neurological disorders.

Journal of Central Nervous System Disease

Elevating the discourse in neurological science.
Publisher: SAGE PUBLICATIONS LTDISSN: 1179-5735Frequency: 1 issue/year

Welcome to the Journal of Central Nervous System Disease, a premier Open Access publication dedicated to advancing the understanding of neurological disorders and their underlying mechanisms. Published by SAGE Publications Ltd, this esteemed journal has been serving the scientific community since 2009 and is committed to disseminating high-quality research that spans from clinical neurology to cellular and molecular neuroscience. With an impressive impact factor, the journal ranks within the top quartiles—Q2 in both Neurology and Clinical Neurology, and Q3 in Cellular and Molecular Neuroscience as of 2023. The journal's indexing in Scopus reflects its significant contribution to the field, being ranked #83 out of 400 in clinical neurology and #38 out of 97 in cellular and molecular neuroscience. This essential resource, based in the United States, is crucial for researchers, clinicians, and students looking to stay at the forefront of neurological science. By providing Open Access options, we ensure that groundbreaking research is readily available to a global audience, fostering collaboration and innovation in the study of central nervous system diseases.

Annals of Indian Academy of Neurology

Advancing Neurological Insights for a Healthier Tomorrow
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0972-2327Frequency: 4 issues/year

Annals of Indian Academy of Neurology is a premier open access journal dedicated to advancing the field of Neurology, serving as a vital resource for researchers, healthcare professionals, and students since its inception in 2006. Published by the esteemed Wolters Kluwer Medknow Publications, this journal has established itself within the academic community, boasting a Q3 quartile ranking in clinical neurology according to the 2023 category quartiles and a Scopus rank placing it in the 35th percentile among 400 comparable journals. With a focus on clinical advancements and research innovations in neurology, the journal aims to disseminate high-quality and impactful studies that address the complex challenges faced in the neurological landscape, particularly within the Indian context. The open access model ensures that the latest research is readily accessible to a global audience, thereby promoting collaboration and knowledge sharing within the neurosciences.

Topics in Stroke Rehabilitation

Exploring the frontiers of neurorehabilitation.
Publisher: TAYLOR & FRANCIS LTDISSN: 1074-9357Frequency: 6 issues/year

Topics in Stroke Rehabilitation, published by Taylor & Francis Ltd, stands as a premier academic journal offering cutting-edge research and insights in the fields of rehabilitation, neurology, and community care. With an impressive impact factor reflecting its strong scholarly influence, this journal not only maintains a distinguished Q1 ranking in Community and Home Care and Rehabilitation but is also recognized in the Q2 category for Clinical Neurology, showcasing its relevance across multiple disciplines. Covering a comprehensive range of topics from neurorehabilitation techniques to patient-centered care strategies, Topics in Stroke Rehabilitation serves as an essential resource for researchers, healthcare professionals, and students dedicated to enhancing the quality of life for individuals recovering from stroke. With an accessible archive dating back to 1996 and continuous publication through 2024, this journal invites collaboration and discourse, fostering advancements in both theoretical knowledge and practical applications within the realm of stroke rehabilitation.

Clinical Neuroradiology

Pioneering Research for Enhanced Patient Care.
Publisher: SPRINGER HEIDELBERGISSN: 1869-1439Frequency: 4 issues/year

Clinical Neuroradiology, published by SPRINGER HEIDELBERG, is a leading journal in the fields of neurology and radiology, focusing on the intersection of clinical practice and cutting-edge imaging technologies. With an impressive impact factor and categorized within Q2 in Neurology (clinical) and Q1 in Radiology, Nuclear Medicine and Imaging, this journal is positioned at the forefront of scientific discourse, facilitating high-quality research dissemination from its origins in 2000 through to 2024. Situated in Germany, Clinical Neuroradiology provides a platform for researchers, professionals, and students to explore the latest advancements and insights in neuroimaging, ensuring that its readership remains at the vanguard of clinical practice. While it does not offer open access, the journal remains committed to fostering a vibrant academic community dedicated to enhancing patient care through innovative neuroradiological techniques and findings.

NEUROREPORT

Shaping the future of neuroscience with every report.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0959-4965Frequency: 18 issues/year

NEUROREPORT is a distinguished journal in the field of neuroscience, published by Lippincott Williams & Wilkins. With an ISSN of 0959-4965 and an E-ISSN of 1473-558X, the journal has established itself as a vital platform for disseminating innovative research and developments in the dynamic area of neuroscience since its inception in 1990. Currently, it is positioned in the Q3 category of the 2023 Journal Rankings, reflecting its respectable standing within the community of neuroscience professionals, ranked #74 out of 113 in general neuroscience on Scopus, placing it in the 34th percentile. While it operates on a traditional subscription model, NEUROREPORT is committed to fostering knowledge sharing in the realm of neurobiology, neuropharmacology, and cognitive studies among researchers, professionals, and students alike. With its broad scope and commitment to scientific excellence, the journal continues to be a cornerstone for those seeking to stay ahead in the evolving landscape of neurological research.

CURRENT NEUROVASCULAR RESEARCH

Fostering Academic Discourse in Neurovascular Studies
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1567-2026Frequency: 4 issues/year

CURRENT NEUROVASCULAR RESEARCH is an esteemed peer-reviewed journal published by Bentham Science Publishers Ltd, focusing on the intricate relationships within the realms of cellular and molecular neuroscience, developmental neuroscience, and neurology. With an ISSN of 1567-2026 and an E-ISSN of 1875-5739, this journal has been contributing to the field since its inception in 2004 and is poised to continue through 2024. As a resource dedicated to disseminating innovative research findings, CURRENT NEUROVASCULAR RESEARCH is recognized within Category Quartiles as Q3 in multiple fields, including Neurology (clinical) and Developmental Neuroscience. Although classified in the Q4 category for Cellular and Molecular Neuroscience, the journal maintains a crucial role in fostering academic discourse and advancing our understanding of neurovascular dynamics. Researchers, professionals, and students will find valuable insights in this journal, offering access to a diverse range of studies that highlight cutting-edge developments in the field.

Cognitive and Behavioral Neurology

Elevating Knowledge in Cognitive and Behavioral Neurology
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1543-3633Frequency: 4 issues/year

Cognitive and Behavioral Neurology is a prominent peer-reviewed journal dedicated to advancing the understanding of cognitive and behavioral aspects of neurological disorders. Published by Lippincott Williams & Wilkins, this journal has established itself as a vital resource for researchers, clinicians, and students in the fields of cognitive neuroscience, neuropsychology, and psychiatry. With an ISSN of 1543-3633 and an E-ISSN of 1543-3641, it offers a robust platform for the dissemination of high-quality research, as evidenced by its positioning in the Q3 quartiles across various categories, including Cognitive Neuroscience and Psychiatry. The journal, which has been actively publishing since 2003, encourages innovative studies that explore the intersection of cognition and behavior in neurological contexts. As a vital contributor to the academic dialogue on these topics, it provides an essential archive of findings and discussions that inform clinical practice and educational approaches, reflecting its commitment to improving patient outcomes and enhancing neurological science.